Corline Biomedical AB
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
CLBIO | ST
Overview
Corporate Details
- ISIN(s):
- SE0006887451
- LEI:
- 549300KYLOA3DVEPZ069
- Country:
- Sweden
- Address:
- Lefflersgatan 5, 754 50 Uppsala
- Website:
- https://corline.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Corline Biomedical AB is a life-science company that develops, manufactures, and markets proprietary heparin-based solutions. It specializes in antithrombotic and anti-inflammatory surface coatings for the medical device industry and applications in regenerative medicine. The company's core offering is the Corline Heparin Surface (CHS™), a unique macro-molecular heparin technology designed to improve the biocompatibility of medical devices and manage immune responses. Its product portfolio also includes drug candidates Renaparin® and Cytoparin™, which are being developed to improve outcomes in kidney transplantation and cell therapies. Corline's technology aims to address unmet clinical needs by making foreign materials and therapeutic cells better tolerated by the patient's body.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Corline Biomedical AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Corline Biomedical AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
